---
layout: post
title: "Recommendations To Reduce the Risk of Transfusion-Transmitted Malaria; Guidance for Industry; Availability"
date: 2026-02-05 19:01:48 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-26711
original_published: 2022-12-08 00:00:00 +0000
significance: 8.00
---

# Recommendations To Reduce the Risk of Transfusion-Transmitted Malaria; Guidance for Industry; Availability

**Published:** February 05, 2026 19:01 UTC
**Source:** Federal Register
**Original Published:** December 08, 2022 00:00 UTC
**Document Number:** 2022-26711

## Summary

The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a final guidance entitled "Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria." The guidance document provides blood establishments that collect blood and blood components with FDA's recommendations to reduce the risk of transfusion-transmitted malaria (TTM). The recommendations contained in the guidance apply to the collection of Whole Blood and blood components, except Source Plasma. The guidance announced in this notice supersedes the guidance entitled "Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria; Guidance for Industry" dated April 2020.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/12/08/2022-26711/recommendations-to-reduce-the-risk-of-transfusion-transmitted-malaria-guidance-for-industry)
- API: https://www.federalregister.gov/api/v1/documents/2022-26711

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
